Kuramochi H, Hiratsuka M, Nagamine S, Takahashi K, Nakamura T, Takeuchi T, Umezawa H
Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan.
J Antibiot (Tokyo). 1988 Feb;41(2):234-8. doi: 10.7164/antibiotics.41.234.
The amine oxidase activities contained in calf serum and human serum were detected at levels of 90.8 and less than 0.1 nmol O2/minute/ml serum, respectively, by measuring oxygen consumption coupled with spermidine oxidation. Deoxyspergualin (NKT-01) and spergualin (SGL) containing spermidine in their structure were also oxidized in calf serum at the rate of 3.6 and 11.6 nmol O2/minute/ml serum, respectively. To investigate whether amine oxidase is essential for NKT-01 and SGL to exhibit their antiproliferative activities or not, the in vitro activities of NKT-01, SGL and polyamines against L1210 cells were examined in the presence of calf or human serum. Polyamines exhibited antiproliferative activity only in the presence of calf serum, while NKT-01 and SGL inhibited cell growth in the presence of both calf and human serum. In the presence of calf serum the activity of NKT-01 was inhibited by aminoguanidine, an amine oxidase inhibitor. Aminoguanidine did not inhibit the activity of NKT-01 in the presence of human serum. The activity of NKT-01 was shown at much lower concentrations in the presence of human serum than that in the presence of calf serum, and was strongly dependent on incubation time. The in vivo activities of NKT-01, SGL and SGL derivatives correlated with their in vitro activities in the presence of human serum. These results suggest that the in vivo antitumor activities of NKT-01, SGL and SGL derivatives may be attributed to a mechanism different from those of amine oxidase-oxidized product and represent a novel growth inhibitory action.
通过测量与亚精胺氧化偶联的氧气消耗,检测到小牛血清和人血清中所含的胺氧化酶活性水平分别为90.8和低于0.1 nmol O₂/分钟/毫升血清。结构中含有亚精胺的去氧精胍菌素(NKT-01)和精胍菌素(SGL)在小牛血清中也分别以3.6和11.6 nmol O₂/分钟/毫升血清的速率被氧化。为了研究胺氧化酶对于NKT-01和SGL发挥其抗增殖活性是否必不可少,在小牛血清或人血清存在的情况下,检测了NKT-01、SGL和多胺对L1210细胞的体外活性。多胺仅在小牛血清存在时表现出抗增殖活性,而NKT-01和SGL在小牛血清和人血清存在时均抑制细胞生长。在小牛血清存在的情况下,NKT-01的活性被胺氧化酶抑制剂氨基胍抑制。在人血清存在的情况下,氨基胍不抑制NKT-01的活性。在人血清存在时,NKT-01在低得多的浓度下就表现出活性,并且强烈依赖于孵育时间。NKT-01、SGL和SGL衍生物的体内活性与其在人血清存在时的体外活性相关。这些结果表明,NKT-01、SGL和SGL衍生物的体内抗肿瘤活性可能归因于一种不同于胺氧化酶氧化产物的机制,代表了一种新的生长抑制作用。